Polyethylene glycol 3350 Disease Interactions
There are 3 disease interactions with polyethylene glycol 3350.
Laxatives (applies to polyethylene glycol 3350) inflammatory bowel disease
Major Potential Hazard, Moderate plausibility.
The use of laxatives is contraindicated in patients with inflammatory bowel disease. Patients with inflammatory bowel disease may experience colonic perforation with use of stimulant laxatives.
Laxatives (applies to polyethylene glycol 3350) intestinal obstruction disorders
Major Potential Hazard, Moderate plausibility. Applicable conditions: Gastrointestinal Obstruction
The use of laxatives is contraindicated in patients with intestinal obstruction disorders. Patients with intestinal obstruction disorders may need their underlying condition treated to correct the constipation. Some laxatives require reduction in the colon to their active form to be effective which may be a problem in patients with intestinal obstruction.
PEG solutions (applies to polyethylene glycol 3350) GI obstruction/perforation
Major Potential Hazard, Moderate plausibility. Applicable conditions: Gastrointestinal Obstruction, Gastrointestinal Perforation, Ulcerative Colitis
The use of polyethylene glycol (PEG) solutions is contraindicated in patients with gastrointestinal obstruction, perforation, or toxic megacolon. If gastrointestinal obstruction or perforation is suspected, appropriate studies should be performed prior to administration of these agents. Use with caution in patients with severe active ulcerative colitis. Increased activity of the gut caused by these agents could worsen these conditions.
Switch to professional interaction data
Polyethylene glycol 3350 drug interactions
There are 222 drug interactions with polyethylene glycol 3350.
Report options
More about polyethylene glycol 3350
- polyethylene glycol 3350 consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (350)
- Side effects
- Dosage information
- During pregnancy
- Drug class: laxatives
- Breastfeeding
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
MiraLAX
MiraLAX (polyethylene glycol) is used as a laxative to treat occasional constipation or irregular ...
Linzess
Linzess (linaclotide) is used to treat chronic idiopathic constipation, irritable bowel syndrome ...
Amvuttra
Amvuttra is used to treat polyneuropathy associated with hereditary transthyretin-mediated ...
Bentyl
Bentyl is used to treat functional bowel or irritable bowel syndrome. Bentyl may also be used for ...
Xifaxan
Xifaxan (rifaximin) is used to treat travelers' diarrhea, irritable bowel syndrome with diarrhea ...
Dulcolax
Dulcolax (bisacodyl) is a laxative used to treat constipation. Includes Dulcolax side effects ...
Hyoscyamine
Hyoscyamine systemic is used for anesthesia, anticholinesterase poisoning, crohn's disease ...
Magnesium oxide
Magnesium oxide systemic is used for constipation, duodenal ulcer, GERD, hypomagnesemia ...
Lubiprostone
Lubiprostone systemic is used for chronic idiopathic constipation, constipation, irritable bowel ...
Erythromycin
Erythromycin is a macrolide antibiotic used to treat bacterial infections. Includes erythromycin ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.